LOS ANGELES, May 26 (Bernama-Xinhua) — Neuralink, Elon Musk’s brain-machine interface company, announced on Friday it has received approval from the US Food and Drug Administration (FDA) to conduct its first in-human clinical study, reported Xinhua. “This is the result of incredible work by the Neuralink team in close collaboration…Read More
ELON MUSKS NEURALINK GETS FDA APPROVAL FOR CLINICAL TRIAL
